Development of neoadjuvant therapy for operable non-small cell lung cancer: an analysis at two DKG-certified lung cancer centers (DGT 2026) - Sep 9, 2026 - Abstract #A-130; Pres time: Sep 10, 2026; 10:30 AM - 10:33 AM; Location: Foyer III; "The development of neoadjuvant or perioperative therapy concepts marks a paradigm shift in the treatment of operable NSCLC.This multimodal therapy requires close interdisciplinary coordination when determining the indication, a precise patient-selective strategy and an adapted perioperative approach."
Clinical • Lung Cancer • Non Small Cell Lung Cancer • Oncology • Solid Tumor
|
|
M. Ried1; V. Gruner1; J. Riedel1; T. Robold2; H.-S. Hofmann1, 2
|